Evogene Announces Filing of Annual Report on Form 20-F
REHOVOT, Israel, March 30, 2023 /PRNewswire/ — Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company focused on revolutionizing product discovery and development in multi…